Options
ARMISEN YAÑEZ, RICARDO AMADO
Preferred name
ARMISEN YAÑEZ, RICARDO AMADO
Main Affiliation
Email
rarmisen@udd.cl
ORCID
Scopus Author ID
22956957700
Now showing
1 - 10 of 12
-
PublicationAbstract C018: Disparities in the access to non-small cell lung cancer´s target therapies in Chile( 2023)
5 -
PublicationDistinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis( 2024)
9 -
PublicationA Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer( 2024)
3 -
PublicationImmune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis( 2021)
Scopus© Citations 29 10 -
PublicationSki Is Required for Tri-Methylation of H3K9 in Major Satellite and for Repression of Pericentromeric Genes: Mmp3, Mmp10 and Mmp13, in Mouse Fibroblasts( 2020)
Scopus© Citations 2 5 -
PublicationNTRK genomic alterations in Latin-American cancer patients.( 2021)
13 -
PublicationADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response( 2020)
Scopus© Citations 17 11 -
PublicationValidation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America( 2021)
Scopus© Citations 4 16 -
PublicationIncrease in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells( 2022)
Scopus© Citations 5 7 -
PublicationBeyond tobacco: genomic disparities in lung cancer between smokers and never-smokers( 2024)
17